Vir Biotechnology, Inc.
VIRBiotechnology
$11.30−3.83%As of Oct 30vs prior close
- Market cap
- $1.9B
- P/E (TTM)
- –
- From 52W high
- −5.28%
- EPS (LTM)
- -$1.86
- Revenue (LTM)
- $303.2M
- Net margin
- -83.00%
- Dividend yield
- 0.00%
Nomior Score
59
Emerging BreakoutSpeculativeTop 28% of the scored universe
Growth41
Quality55
Value47
Momentum92
Resilience45
Growth
+49.77%revenue a year over 8 fiscal years
YE17 $2.7MLTM $303.2M
Connections
Revenue to profitQ2 YE26
34% of revenue became net profit, up 9173 pts on a year.
Who owns it
2funds